Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

http://www.wikidata.org/entity/Q36940342

about

Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases Gut microbes and host physiology: what happens when you host billions of guests?Targeting gut microbiota: a potential promising therapy for diabetic kidney disease The Gut as a Source of Inflammation in Chronic Kidney Disease Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease Effects of rhein on intestinal epithelial tight junction in IgA nephropathy.Characteristics and functional relevance of apolipoprotein-A1 and cholesterol binding in mammary gland tissues and epithelial cells Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.Alterations of intestinal barrier and microbiota in chronic kidney disease.Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.Gut microbiome in chronic kidney disease.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO Protein Nutrition and Malnutrition in CKD and ESRD.The effects of acute renal failure on drug metabolism.From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology.The intestine and the kidneys: a bad marriage can be hazardous.Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.Urea and chronic kidney disease: the comeback of the century? (in uraemia research).Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms.Gut microbiome in chronic kidney disease: challenges and opportunities.Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.Resistant starch as a novel dietary strategy to maintain kidney health in diabetes mellitus.Lanthanum-Induced Gastrointestinal Histiocytosis.Asymptomatic Effluent Protozoa Colonization in Peritoneal Dialysis Patients.A novel SCFA receptor, the microbiota, and blood pressure regulation.(1→3)-β-D-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study.Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.Effects of dietary fibre and protein on urea transport across the cecal mucosa of piglets.

P2860

Q26746677-FC98C684-2687-47CA-A43E-ACA7257F8E58 Q26822836-D88A1936-F387-4AA5-8769-EBFB61D60935 Q28078235-39A1E9E0-92CD-45C8-9B1B-380D698DFADD Q28081781-E8D347B9-D0EF-4BD0-997A-077E3AD891D8 Q28085593-90B843D1-5050-4F88-A906-DC1C3B62AEE3 Q30421083-3CCED9B1-F0A1-4A08-AFD6-D2BED1BEFD98 Q33613115-53A4BB12-811B-422B-B90C-F270A73307BE Q33725646-E32BA9E3-43E1-47A6-AAC8-BF09A887DF89 Q34663426-24DC49E0-92EA-407D-BCB3-E32FE487E796 Q34830649-413AB6B7-357B-4B1F-8109-123B377962FA Q34922789-FAC8C4ED-D888-43A2-8237-BB02C81C427D Q35156688-1A109611-394F-4ED6-AB67-BC1AD681096B Q35168767-3221028E-576B-4F9A-A6D2-682489009002 Q35239148-2913D371-F84E-4F2F-B3EB-889F5B0338BF Q35530569-44830E10-9F67-47E7-884E-9564C98E62FB Q35764101-7FE58E27-21A7-45CA-9FD6-5F4E719EF5EF Q35891553-CFA62B35-2A3D-4C8F-AF1E-32ECB4F84EEF Q35966150-B784E49C-D715-44CA-AB3C-B53CE0285DCC Q36902202-B2C7336C-7E1E-4F1E-90E2-00E65E6A7ADA Q37217519-8AA4AC2E-4EE4-4DD9-ABC6-CA8BF7DE44B4 Q37263314-4375F1E7-6B42-4BC6-A879-398BC9BBAA57 Q37646555-E4D87470-40BC-4DC2-8D53-667AAC9073D4 Q37729646-7B2C37E6-9D12-4F5F-A896-379A15154487 Q38145416-647D0E14-E2B3-4E64-9E66-6E9272A51F01 Q38255944-EA0B8322-EB60-4763-B9F3-CD1613BBBF43 Q38393212-8EF907DD-4DF3-433A-80A4-A61EF40A0DE7 Q38425357-CFC53477-D97A-435C-8703-4D86068C4689 Q38730770-01944764-C5FF-41D5-94A1-C024EA1DEB02 Q38757951-A8F3D4D2-CD99-4CEC-8B08-EE0CBEE5FBD7 Q38821293-883DCCFD-F21C-4B8F-9CD2-3437976400CA Q38836354-B1E7269C-1C26-4E5A-B617-6432B4B49C7F Q38941009-7432A111-31D4-4AA7-AE02-497F920DB791 Q39263579-67139B10-E413-49B6-B96F-0787567641C8 Q40148090-D343B4BC-231F-488E-AB20-4263C4E54487 Q40530031-AA9063C6-1AE9-4F26-94F5-578D29D2DDF9 Q40899577-DE7A20D2-D9C6-40DF-BFA9-D26B12031BC0 Q41349103-40A8B62E-5448-43B1-8E18-19C91D9DDE66 Q42042998-60A8055C-ED8C-4F98-86BC-491234883DEF Q42551130-BF132993-E5C5-4E84-B2FB-8819FF0CCB7C Q43516908-B77BFAFF-5B8E-44D3-8B3C-A5C42D5DAF72

P2860

Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

http://www.wikidata.org/entity/Q36940342

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Role of urea in intestinal bar ...... ion in chronic kidney disease.

@en

type

label

Role of urea in intestinal bar ...... ion in chronic kidney disease.

@en

prefLabel

Role of urea in intestinal bar ...... ion in chronic kidney disease.

@en

P1433

Q36940342-1B7459FD-D271-4467-AB59-286C4BC6751C

P1476

Q36940342-0656A8E3-752C-432F-A95D-F350050CD987

P2093

Q36940342-4C0299EF-8ADC-4F5D-81A9-30089424759F

Q36940342-7AF23D62-96CF-4264-9F90-4F3537C070C3

Q36940342-8148E890-3FE3-465E-8932-6D8E79DD6552

P2860

Q36940342-0873BE69-142E-4220-9DAB-8ACAAF3DF9EB

Q36940342-47891BF3-9C61-4E6C-B8DC-DE85AF605AF4

Q36940342-5B336AF3-4941-401A-B446-B19843B65507

Q36940342-60884348-0024-43E6-A6A8-BA0D45C0E288

Q36940342-650632C9-6A60-474D-A528-061E73F5F162

Q36940342-6EE17022-80BF-4CAE-91C6-FC7C69DBF501

Q36940342-74A6AC75-AE3A-4A87-9669-46CDF83C625B

Q36940342-92DC7BAE-67DC-4ED6-9273-9F3AAA69B846

Q36940342-9F5DA206-C0A6-4C74-94AB-AEB67509C285

Q36940342-A6048EB1-191B-4D91-8088-C010F1B628CB

P304

Q36940342-4EC88F75-8752-45A1-A977-D9C2BAE50A48

P31

Q36940342-64AB07C0-9E3A-4F39-9305-D9B6B4A739B0

P356

Q36940342-F1257A89-3B3D-4FE6-A691-D83C310CD943

P433

Q36940342-8F5F8257-697A-4D2C-9ED6-A0BD1C6C3F9B

P478

Q36940342-4FA7A911-C80A-46AC-8C6E-659EE73EB88D

P577

Q36940342-F9F5D718-342D-48D2-9BD1-2362F2E0E971

P698

Q36940342-163C5172-8646-4E9D-9535-3E9D815D153B

P932

Q36940342-7FB6C15C-4645-4618-AFAB-12679B61A4FD

P356

P1433

American Journal of Nephrology

P1476

Role of urea in intestinal bar ...... ion in chronic kidney disease.

@en

P2093

Jun Yuan

http://www.w3.org/2001/XMLSchema#string

Keith Norris

http://www.w3.org/2001/XMLSchema#string

Nosratola D Vaziri

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

Caecal pH and ammonia in experimental uraemia.

Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.

Effect of uremia on structure and function of immune system.

Occluding junction structure-function relationships in a cultured epithelial monolayer.

Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients.

Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium.

CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.

Inflammation in end-stage renal disease--what have we learned in 10 years?

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000345969

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23258127

http://www.w3.org/2001/XMLSchema#string

P932

3686571

http://www.w3.org/2001/XMLSchema#string